newsfilter
← Latest News
Business Wire·

Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

Final 2025 global cohort onboarding, with applications now open for 2026 Charles River Laboratories International, Inc. (NYSE:CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program